Marian Mitroiu

Applicability and added value of novel methods to improve drug development in rare diseases

Marian Mitroiu, Katrien Oude Rengerink, Caridad Pontes et al. · Orphanet Journal of Rare Diseases · 2018 · 22 citations · Full text

Estimation of treatment effects in short‐term depression studies. An evaluation based on the <scp>ICH E9</scp>(<scp>R1</scp>) estimands framework

Marian Mitroiu, Steven Teerenstra, Katrien Oude Rengerink et al. · Pharmaceutical Statistics · 2022 · 16 citations · Full text

Treatment Effect, Targeted Estimand, Mental Health +21

Comparing tocilizumab biosimilar BAT1806/BIIB800 with reference tocilizumab in patients with moderate-to-severe rheumatoid arthritis with an inadequate response to methotrexate: a phase 3, randomised, multicentre, double-blind, active-controlled clinical trial

Xiaomei Leng, Piotr Leszczyński, Sławomir Jeka et al. · The Lancet Rheumatology · 2023 · 15 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +11

The SNAP Trial: 2-Year Results of a Double-Blind Multicenter Randomized Controlled Trial of a Silicon Nitride Versus a PEEK Cage in Patients After Lumbar Fusion Surgery

R.F.M.R. Kersten, F. Cumhur Öner, Mark P. Arts et al. · Global Spine Journal · 2021 · 14 citations · Full text